No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma
Document Type
Letter to the Editor
Publication Date
9-4-2023
Publication Title
Bone Marrow Transplantation
First Page
1390
Last Page
1393
PubMed ID
37666957
Volume
58
Issue
12
Recommended Citation
Knight, Tristan E.; Ahn, Kwang Woo; Hebert, Kyle M.; Atshan, Rasha; Wall, Donna A.; Chiengthong, Kanhatai; Lund, Troy C.; Prestidge, Tim; Rangarajan, Hemalatha G.; Dvorak, Christopher C.; Auletta, Jeffery J.; Kent, Michael; Hashem, Hasan; Talano, Julie-An; Rotz, Seth J.; Fraint, Ellen; Myers, Kasiani C.; Leung, Wing; Sharma, Akshay; Bhatt, Neel S.; Driscoll, Timothy A.; Yu, Lolie C.; Schultz, Kirk R.; Qayed, Muna; Broglie, Larisa; Eapen, Mary; and Yanik, Gregory A., "No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma" (2023). School of Medicine Faculty Publications. 2142.
https://digitalscholar.lsuhsc.edu/som_facpubs/2142
10.1038/s41409-023-02092-3